Influenza, also called the flu, spreads around the world in a yearly outbreak resulting in about three to five million cases of severe illness and about 250,000 to 500,000 deaths. In the Northern and Southern parts of the world outbreaks occur mainly in winter while in areas around the equator outbreaks may occur at any time of the year. Serious outcomes of flu infection can result in hospitalization or death. Some people, such as older people, young children, and people with certain health conditions can be at high risk for serious flu complications.
The flu is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and lungs. It can cause mild to severe illness, and at times can lead to death. Complications for flu can include bacterial pneumonia, ear infections, sinus infections, dehydration, and worsening of chronic medical conditions, such as congestive heart failure, asthma, or diabetes. It is very difficult to distinguish the flu from other viral or bacterial causes of respiratory illnesses on the basis of symptoms alone. Applied BioCode is currently developing a Respiratory Pathogen Panel* for common respiratory pathogens including viruses and bacteria. The rapid and accurate identification of these potential pathogens can help to determine how a physician will treat an upper respiratory tract infection.
The Applied BioCode Respiratory Pathogen Panel is run in a low cost, high throughput 96-well microplate format. It will simultaneously detect and differentiate the presence of 21 respiratory pathogens in nasopharyngeal swabs in one well. The Applied BioCode Respiratory Pathogen Panel* will be available on our new BioCode MDx 3000 System* which will combine the amplification, hybridization, and detection steps for this assay. The automation of these steps into a single system will decrease costs, hands on time, and minimize potential contamination risk. The BioCode MDx 3000 provides the ability to suppress results for any viral or bacterial targets that are not ordered by the doctor. The Respiratory Pathogen Panel can also be run on the BioCode MDx 3000 at the same time with our Gastrointestinal Pathogen Panel*.
|Applied BioCode Respiratory Pathogen Panel (RPP)*|
|Viruses - 18 Targets||
• RSV A
|Bacteria - 3 Targets||
• Bordetella pertusssis
* The product is currently Under Development.
For more information about the technology of any of these products or to discuss a potential study, please contact us via: